论文部分内容阅读
目的:通过对我院2013-2015年度我院住院患者PPIs使用情况进行分析,为临床合理使用PPIs提供参考,有效促进临床合理用药。方法:从医院信息系统中提取2013-2015年我院PPIs的使用品种、数量、销售金额,计算DDDs及DDDc,进行回顾性评价与分析。结果:2013-2015年,兰索拉唑类销售金额一直排在第1位,其次为泮托拉唑类,DDDs最高的为注射用兰索拉唑,DDDc最高为注射用艾司奥美拉唑。结论:我院PPIs需完善临床应具体指导细则,加强对PPIs使用的监管力度。
OBJECTIVE: To analyze the use of PPIs in our hospital from 2013 to 2015 in our hospital to provide a reference for clinical rational use of PPIs, and to effectively promote the rational use of clinical medicine. Methods: The types, quantities and sales amount of PPIs in our hospital from 2013 to 2015 were extracted from the hospital information system, DDDs and DDDc were calculated, and retrospectively evaluated and analyzed. Results: From 2013 to 2015, the sales amount of lansoprazole was always in the first place, followed by pantoprazole, the highest DDDs were lansoprazole for injection, the highest DDDc was esomeprazole for injection Azole. Conclusion: Our hospital PPIs need to improve the clinical guidance should be specific, to strengthen the supervision of the use of PPIs.